BALDANTI, FAUSTO
 Distribuzione geografica
Continente #
NA - Nord America 13.022
AS - Asia 10.526
EU - Europa 7.495
SA - Sud America 1.742
AF - Africa 509
OC - Oceania 28
Continente sconosciuto - Info sul continente non disponibili 7
Totale 33.329
Nazione #
US - Stati Uniti d'America 12.627
CN - Cina 3.941
SG - Singapore 2.667
IE - Irlanda 1.558
HK - Hong Kong 1.416
BR - Brasile 1.298
RU - Federazione Russa 1.151
VN - Vietnam 1.127
IT - Italia 907
DE - Germania 893
FI - Finlandia 651
FR - Francia 568
GB - Regno Unito 479
UA - Ucraina 427
IN - India 344
SE - Svezia 292
ZA - Sudafrica 282
CA - Canada 185
AR - Argentina 156
MX - Messico 139
BD - Bangladesh 138
JP - Giappone 138
IQ - Iraq 117
TR - Turchia 102
PL - Polonia 97
NL - Olanda 91
ES - Italia 84
EC - Ecuador 65
ID - Indonesia 65
PK - Pakistan 59
AT - Austria 57
VE - Venezuela 55
CO - Colombia 53
PH - Filippine 53
MA - Marocco 52
BE - Belgio 48
SA - Arabia Saudita 40
CL - Cile 39
UZ - Uzbekistan 34
CZ - Repubblica Ceca 26
KE - Kenya 26
AU - Australia 25
PY - Paraguay 25
LT - Lituania 24
IL - Israele 23
RO - Romania 23
AE - Emirati Arabi Uniti 22
AZ - Azerbaigian 22
ET - Etiopia 22
IR - Iran 22
EG - Egitto 21
MY - Malesia 21
CH - Svizzera 20
JO - Giordania 20
PE - Perù 19
TN - Tunisia 19
DZ - Algeria 18
JM - Giamaica 17
KR - Corea 16
KZ - Kazakistan 15
NP - Nepal 15
GR - Grecia 14
MU - Mauritius 14
SN - Senegal 13
BO - Bolivia 12
UY - Uruguay 12
SY - Repubblica araba siriana 11
AL - Albania 10
CR - Costa Rica 10
OM - Oman 10
PA - Panama 10
KG - Kirghizistan 9
LV - Lettonia 9
TH - Thailandia 9
HR - Croazia 8
TT - Trinidad e Tobago 8
BY - Bielorussia 7
DO - Repubblica Dominicana 7
GE - Georgia 7
AM - Armenia 6
AO - Angola 6
BH - Bahrain 6
LB - Libano 6
LK - Sri Lanka 6
RS - Serbia 6
HN - Honduras 5
LA - Repubblica Popolare Democratica del Laos 5
PS - Palestinian Territory 5
PT - Portogallo 5
QA - Qatar 5
SR - Suriname 5
TW - Taiwan 5
DK - Danimarca 4
EE - Estonia 4
EU - Europa 4
HU - Ungheria 4
LU - Lussemburgo 4
MD - Moldavia 4
NG - Nigeria 4
SK - Slovacchia (Repubblica Slovacca) 4
Totale 33.239
Città #
Dublin 1.535
San Jose 1.506
Singapore 1.452
Hong Kong 1.386
Ashburn 1.370
Chandler 1.314
Dallas 1.206
Beijing 791
Jacksonville 575
Nanjing 505
Boardman 497
New York 391
Los Angeles 386
Ho Chi Minh City 375
Lauterbourg 374
Munich 346
Helsinki 327
Princeton 288
Wilmington 281
Hanoi 275
Lawrence 257
Shanghai 254
Johannesburg 242
Nanchang 232
Moscow 216
Redondo Beach 192
Medford 188
Hebei 183
Milan 176
Shenyang 173
Changsha 165
Jiaxing 142
Pavia 135
Turku 133
São Paulo 129
Tokyo 126
Ann Arbor 123
Buffalo 117
Hangzhou 110
Council Bluffs 106
Orem 102
Tianjin 102
Seattle 99
Houston 87
The Dalles 86
Frankfurt am Main 84
Chennai 83
Woodbridge 82
Warsaw 80
Brooklyn 78
Santa Clara 78
Toronto 73
Da Nang 62
Nuremberg 62
London 59
Fairfield 56
Poplar 56
Mexico City 54
Montreal 54
Baghdad 52
Denver 52
Columbus 51
Atlanta 50
Pune 49
Rome 49
Falkenstein 48
Washington 48
Chicago 47
San Francisco 47
Phoenix 45
Boston 43
Brussels 42
Haiphong 41
Norwalk 41
Rio de Janeiro 39
Düsseldorf 37
Stockholm 36
Ankara 35
Mumbai 34
Guangzhou 33
Tashkent 33
Amsterdam 31
Biên Hòa 31
Belo Horizonte 30
Zhengzhou 30
Paris 28
Jinan 27
Quito 27
Falls Church 26
Manchester 24
Piscataway 24
Nairobi 23
Porto Alegre 23
Addis Ababa 21
Istanbul 21
Santiago 21
Vienna 21
Baku 20
Dhaka 20
Guarulhos 20
Totale 21.436
Nome #
Venous thromboembolism and COVID-19: a single center experience from an academic tertiary referral hospital of Northern Italy 172
Compartmentalized replication of sars-cov-2 in upper vs. Lower respiratory tract assessed by whole genome quasispecies analysis 150
Adoptive transfer of herpesvirus-specific cytotoxic T lymphocytes in transplant recipients 149
Correction to: Venous thromboembolism and COVID-19: a single center experience from an academic tertiary referral hospital of Northern Italy (Internal and Emergency Medicine, (2021), 16, 5, (1141-1152), 10.1007/s11739-020-02550-6) 149
Accumulation of defective HIV-1 variants in a patient with slow disease progression. 148
A snapshot of the immunogenicity, efficacy and safety of a full course of BNT162b2 anti-SARS-CoV-2 vaccine in cancer patients treated with PD-1/PD-L1 inhibitors: a longitudinal cohort study 148
Low risk for SARS-CoV2 symptomatic infection and early complications in paediatric patients during the ongoing CoVID19 epidemics in Lombardy 146
Detection of haemagglutinin D222 polymorphisms in influenza A(H1N1)pdm09-infected patients by ultra-deep pyrosequencing. 139
Depletion of circulating IgM memory B cells predicts unfavourable outcome in COVID-19 138
Impact of COVID-19 on liver function: results from an internal medicine unit in Northern Italy 136
Lack of SARS-CoV-2 RNA environmental contamination in a tertiary referral hospital for infectious diseases in Northern Italy 136
Acute cytomegalovirus infection as a cause of venous thromboembolism. 134
Methotrexate and glucocorticoids, but not anticytokine therapy, impair the immunogenicity of a single dose of the BNT162b2 mRNA COVID-19 vaccine in patients with chronic inflammatory arthritis 134
Baseline and Breakthrough Resistance Mutations in HCV Patients Failing DAAs 131
Low risk for SARS-CoV2 symptomatic infection and early complications in paediatric patients during the ongoing CoVID19 epidemics in Lombardy 131
Venous thromboembolism and COVID-19: a single center experience from an academic tertiary referral hospital of Northern Italy 131
Clinical characteristics of coronavirus disease (COVID-19) early findings from a teaching hospital in Pavia, North Italy, 21 to 28 February 2020 130
A new Real-Time RT-PCR Assay for Detection of Human Enterovirus 68 (EV-D68) in Respiratory Samples. 126
T-lymphocytes with high proliferative capacity correlate with control of viral suppression in chronically untreated HIV-1 infected individual 126
Herpes virus-6 chromosomal integration misled the management of Crohn’s disease 126
Contribution of Enteroviruses to Acute Central Nervous System or Systemic Infections in Northern Italy (2015-2017): Is It Time to Establish a National Laboratory-Based Surveillance System? 126
EBV DNA increase in COVID-19 patients with impaired lymphocyte subpopulation count 125
Incidence of SARS-CoV-2 infection in health care workers from Northern Italy based on antibody status: immune protection from secondary infection- A retrospective observational case-controlled study 124
Concomitant Resistance to Cefiderocol and Ceftazidime/Avibactam in Two Carbapenemase-Producing Klebsiella pneumoniae Isolates from Two Lung Transplant Patients 123
Zika virus isolation from semen 123
The pentameric complex of human cytomegalovirus: Cell tropism, virus dissemination, immune response and vaccine development 123
Systematic analysis of human oncogenic viruses in colon cancer revealed EBV latency in lymphoid infiltrates. 122
19n01, a Broadly Neutralizing Antibody Against Omicron BA.1, BA.2, BA.4/5, and Other SARS-CoV-2 Variants of Concern 121
Detection of Active Epstein-Barr Virus Infection in Duodenal Mucosa of Patients With Refractory Celiac Disease 121
Different drug-resistant influenza A(H3N2) variants in two immunocompromised patients treated with oseltamivir during the 2011-2012 influenza season in Italy. 120
A novel human enterovirus C (EV-C118) identified in two children hospitalised because of acute otitis media and community-acquired pneumonia in Israel. 119
Interim 2017/18 influenza seasonal vaccine effectiveness: Combined results from five European studies 119
12 weeks ombitasvir/paritaprevir–ritonavir + ribavirin achieve high SVR rates in HCV-4 patients with advanced fibrosis 119
Analysis of the humoral and cellular immune response after a full course of BNT162b2 anti-SARS-CoV-2 vaccine in cancer patients treated with PD-1/PD-L1 inhibitors with or without chemotherapy: an update after 6 months of follow-up 118
Torque teno virus and cancers: current knowledge 117
Diagnosis and counseling of fetal and neonatal HCMV infection. 117
Preemptive therapy of EBV-related lymphoproliferative disease after pediatric haploidentical stem cell transplantation 117
Liver fibrosis, microbial translocation and immune activation markers in HIV and HCV infections and in HIV/HCV co-infection. 117
Segregation of virulent influenza A(H1N1) variants in the lower respiratory tract of critically ill patients during the 2010-2011 seasonal epidemic 117
Use of a DNAemia cut-off for monitoring human cytomegalovirus infection reduces the number of preemptively treated children and young adults receiving hematopoietic stem-cell transplantation compared with qualitative pp65 antigenemia. 117
Human cytomegalovirus and Epstein-Barr virus infection in inflammatory bowel disease: Need for mucosal viral load measurement. 116
Usutu Virus Antibodies in Blood Donors and Healthy Forestry Workers in the Lombardy Region, Northern Italy 114
A snapshot of the immunogenicity, efficacy and safety of a full course of BNT162b2 anti-SARS-CoV-2 vaccine in cancer patients treated with PD-1/PD-L1 inhibitors: a longitudinal cohort study 113
Viral outbreaks in neonatal intensive care units: what we do not know. 113
Postinfectious neurologic syndromes: A prospective cohort study 113
Cross-neutralization of four paramyxoviruses by a human monoclonal antibody. 113
Expanding usutu virus circulation in italy: Detection in the Lazio region, central Italy, 2017 to 2018 113
Guillain-Barré syndrome associated with SARS-CoV-2 113
Enterovirus-D68 (EV-D68) in pediatric patients with respiratory infection: The circulation of a new B3 clade in Italy 113
Diagnosing acute encephalitis in patients with hematological disorders: caveats and pitfalls 113
Prevalence of SARS-CoV-2 specific neutralising antibodies in blood donors from the Lodi Red Zone in Lombardy, Italy, as at 06 April 2020 112
Bispecific IgG neutralizes SARS-CoV-2 variants and prevents escape in mice 112
SARS-CoV-2 vaccine breakthrough infections with the alpha variant are asymptomatic or mildly symptomatic among health care workers 111
Rules-based HIV-1 genotypic resistance interpretation systems predict 8 week and 24 week virological antiretroviral treatment outcome and benefit from drug potency weighting. 110
Authors’ reply: Two severe human cases due to swine influenza a (H1N1)v in October 2016 in Europe were chronologic coincident yet distinct events 110
Frequent NS5A and multiclass resistance in almost all HCV genotypes at DAA failures: What are the chances for second-line regimens? 110
Human enterovirus and parechovirus infections in newborns with sepsis-like illness and neurological disorders. 109
Persistent human cosavirus infection in lung transplant recipient, Italy. 109
Epstein-Barr Virus positive aggressive lymphoma as a consequence of immunosuppression after multiple salvage treatments for follicular lymphoma. 109
Baseline amino acid substitutions in the NS5A ISDR and PKR binding domain of hepatitis C and different fibrosis levels and levels of development of hepatocellular carcinoma in patients treated with DAAs 109
Impact of immunosuppressive treatment on the immunogenicity of mRNA Covid-19 vaccine in vulnerable patients with giant cell arteritis 109
A case of leprosy in a nonendemic country 109
Comparison of immunologic and molecular assays for the diagnosis of gastrointestinal viral infections. 108
Occult HIV infection in a large sample of health-care users in Lombardy, Italy in 2014-2015: Implications for control strategies 108
Cellular DNA quantification in respiratory samples for the normalization of viral load: a real need? 108
Adoptive Transfer of JC Virus-Specific T Lymphocytes for the Treatment of Progressive Multifocal Leukoencephalopathy 108
Cytomegalovirus infection management in solid organ transplant recipients across European centers in the time of molecular diagnostics: An ESGICH survey 107
Prevalence of acquired resistance mutations in a large cohort of perinatally infected HIV-1 patients 107
Neutrophil Extracellular Traps Induce the Epithelial-Mesenchymal Transition: Implications in Post-COVID-19 Fibrosis 106
Characterization of immune response against monkeypox virus in cohorts of infected patients, historic and newly vaccinated subjects 106
Comparison of three different methods for the evaluation of IL28 and ITPA polymorphisms in patients infected with HCV. 106
Human cytomegalovirus pp67 mRNAemia versus pp65 antigenemia for guiding preemptive therapy in heart and lung transplant recipients: a prospective, randomized, controlled, open-label trial 106
A collaborative study to establish the 1st WHO International Standard for human cytomegalovirus for nucleic acid amplification technology 106
Acute respiratory distress syndrome in adenovirus type 4 pneumonia: A case report 106
Allogeneic hematopoietic stem cell transplantation may restore gluten tolerance in patients with celiac disease. 106
Plasma from donors recovered from the new Coronavirus 2019 as therapy for critical patients with COVID-19 (COVID-19 plasma study): a multicentre study protocol 106
Complete genome characterization of enterovirus 104 circulating in Northern Italy shows recombinant origin of the P3 region. 105
High Frequencies of Functional Virus-Specific CD4+ T Cells in SARS-CoV-2 Subjects With Olfactory and Taste Disorders 105
Characterization of varicella-zoster (Vzv) specific t cell response in healthy subjects and transplanted patients by using enzyme linked immunospot (elispot) assays 105
Detection of Epstein-Barr virus-specific memory CD4+ T cells using a peptide-based cultured enzyme-linted immunospot assay. 104
Emerging and re-emerging virus infections in neonates and young pediatric patients. 104
Monitoring of human cytomegalovirus DNAemia during primary infection in transmitter and non-transmitter mothers 104
Human Cytomegalovirus-Specific Memory CD4+T-Cell Response and Its Correlation with Virus Transmission to the Fetus in Pregnant Women with Primary Infection 104
Genome characterisation of enteroviruses 117 and 118: a new group within human enterovirus species C. 104
Assessment and prevention of cytomegalovirus infection in allogeneic hematopoietic stem cell transplant and in solid organ transplant: A multidisciplinary consensus conference by the Italian GITMO, SITO, and AMCLI societies 104
Chikungunya infection in a human immunodeficiency virus-infected kidney transplant recipient returning to Italy from the Dominican Republic 103
FilmArray GI panel performance for the diagnosis of acute gastroenteritis or hemorragic diarrhea 103
Genotypic testing on HIV-1 DNA as a tool to assess HIV-1 co-receptor usage in clinical practice: results from the DIVA study group. 102
Antibody-based assay discriminates Zika virus infection from other flaviviruses 102
Detection of SARS-CoV-2 in Cancellous Bone of Patients with COVID-19 Disease Undergoing Orthopedic Surgery: Laboratory Findings and Clinical Applications 101
Imported hantavirus cardiopulmonary syndrome in an Italian traveller returning from Cuba. 101
Dissociation between serum and liver hepatitis C virus RNA levels in patients coinfected with human immunodeficiency virus 101
Evolution of transmitted HIV-1 drug resistance and viral subtypes circulation in Italy from 2006 to 2016 101
Differential Kinetics of Effector and Memory Responses Induced by Three Doses of SARS-CoV-2 mRNA Vaccine in a Cohort of Healthcare Workers 100
Impact of human metapneumovirus and human cytomegalovirus versus other respiratory viruses on the lower respiratory tract infections of lung transplant recipients. 100
Dengue Virus-Specific Humoral and T Cellular Immune Response in Italian Residents and Travelers Returning from Endemic Areas 100
Guillain-Barré syndrome associated with the D222E variant of the 2009 pandemic influenza A (H1N1) virus: Case report and review of the literature 100
Skewed B cells in chronic hepatitis C virus infection maintain their ability to respond to virus-induced activation 99
HIV integrase variability and genetic barrier in antiretroviral naïve and experienced patients. 99
Maternal, fetal, and neonatal parameters for prognosis and counseling of HCMV congenital infection. 99
Totale 11.582
Categoria #
all - tutte 149.740
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 149.740


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021292 0 0 0 0 0 0 0 0 0 145 107 40
2021/20221.251 23 14 27 46 52 29 33 65 72 42 179 669
2022/20234.066 405 278 77 280 328 348 6 203 1.820 41 205 75
2023/20242.446 278 396 101 128 252 594 184 159 29 100 106 119
2024/20256.630 163 452 141 215 112 391 372 382 1.658 365 727 1.652
2025/202614.809 1.189 1.051 1.881 1.796 1.870 638 2.983 811 1.557 1.033 0 0
Totale 33.985